Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Cardiome Pharma Corp T.COM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  CRME

Cardiome Pharma Corp is a specialty pharmaceutical company engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.
Price: $12.15 Volume: 12,740
Change: $-0.10 % Change: -0.82%
Day High/Low: 12.55/12.10 52 Week High/Low: 13.80/6.62
Last Traded: February 26, 2015 10:45 Transaction Volume: 100
Open: 12.48 Previous Close: 12.25
Bid: 12.10 Ask: 12.50
Bid Size: 100 Ask Size: 3700
Market Cap: 201.6m Shares Out: 16.6m
PE Ratio: N/A Dividend Yield: N/A


Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

When you're standing on a launchpad and a rocket is taking off, the best place to be is on the rocket.

Chris Parry   November 19, 2013
0 stars

Insider snaps up 4,700 Parallel Energy Trust shares

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   October 1, 2013
0 stars

Latest Bullboard Posts

  • RE:RE:input

    0 stars

    I haveTRL,and PLI,and DND   .DND and PLI have  been the best for me but only after a long wait.Many years for DND as a matter of fact.

    2 stars

  • RE:input

    0 stars

    NOT the only one , but after Merck left , i guess nobody believed in the C° anymore !  I hold all my shares (unless some unexpected bad...

    1 star

  • input

    0 stars

    This stock is spectacular lately.But because its relatively expensive it weeds out the kids with their childish commentary.Makes for a...

    2 stars

  • Positive Data From Phase 3 Trial, Cardiome

    0 stars

    Cardiome Pharma Corp. (COM.TO) Touts Positive Data From Phase 3 BRINAVESS® Trial Cardiome Announces Positive Results from the BRINAVESS®...

    2 stars

  • News to come on the 18th?

    0 stars

    1.5 stars